2021
Unusual complications after MammoSite brachytherapy: out‐of‐field rib fracture and Mondor's disease
Rahimy E, Evans S. Unusual complications after MammoSite brachytherapy: out‐of‐field rib fracture and Mondor's disease. Precision Radiation Oncology 2021, 5: 205-207. DOI: 10.1002/pro6.1128.Peer-Reviewed Original ResearchRib fracturesMondor's diseaseMammoSite brachytherapyRare clinical entityPartial breast irradiationMaximum point doseRare complicationBreast irradiationClinical entityTumor recurrenceUnusual complicationRisk factorsPrescribed doseRadiation oncologistsDiseasePoint doseComplicationsFirst caseRecent reportsBrachytherapyDoseAbstract Recent reportsFracturesRecurrenceOncologists
2016
Modern Radiation Therapy for Left-Sided Breast Cancer: An Analysis of Mean Heart Dose Within Diverse Practice Settings
Hong J, Gross C, Shafman T, Hu X, Yu J, Ross R, Dosoretz A, Park H, Finkelstein S, Soulos P, Evans S. Modern Radiation Therapy for Left-Sided Breast Cancer: An Analysis of Mean Heart Dose Within Diverse Practice Settings. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s209. DOI: 10.1016/j.ijrobp.2016.06.520.Peer-Reviewed Original ResearchA Biologically Effective Dose of ≥105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
Stahl J, Ross R, Harder E, Mancini B, Soulos P, Dosoretz A, Finkelstein S, Shafman T, Husain Z, Evans S, Yu J, Gross C, Decker R. A Biologically Effective Dose of ≥105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s174-s175. DOI: 10.1016/j.ijrobp.2016.06.438.Peer-Reviewed Original Research